Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117365) titled 'A Study on the Application of Femoral Nerve Block with Different Concentrations of Liposomal Bupivacaine in the Perioperative Period of Patients with Femoral Shaft Fractures' on Jan. 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Ethics Committee of the 960th Hospital of the Chinese People's Liberation Army

Condition: Femoral shaft fracture

Intervention: Group 1:Ropivacaine Hydrochloride 0.25% Group 2:Bupivacaine Liposome 0.665% Group 3:Bupivacaine Liposome 0.887%

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2024-01-04

Target Sample Size: Group...